Trial: 202002190

A Phase III Study of Consolidative Radiotherapy in Patients with Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)

Phase

III

Principal Investigator

Park, Haeseong

Disease Site

Esophagus; Metastatic Disease; Stomach

Learn more about this study at: clinicaltrials.gov